Delivery Order SPE2DR25D1100-SPE2DR26FCT1S
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,683.68 on December 4, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures with an ultimate completion date of December 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This award...
- The Defense Logistics Agency awarded a $36,811.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for Biktarvy 50-200-25 mg tablets (30-count units). This is a non-set-aside contract with an ultimate completion date of December 5, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $55,504.20 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of December 2, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $47,060.31 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by November 17, 2025. The delivery order was issued on November 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units, with a contract ceiling value of $57,309.65. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by November 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This contract, valued at $70,069.04, represents a firm fixed price delivery order with an ultimate completion date of December 8, 2025. The award was competitively procured without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $33,628.98 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with a completion date of December 9, 2025, and no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $35,151.10 to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for completion by November 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,819.09 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This non-competitive, firm fixed-price delivery order, issued on December 8, 2025, with completion targeted for December 9, 2025, represents a purchase of pharmaceutical products for federal medical supply needs. The award was fulfilled from the contractor's place of performance in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,548.16 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This competitive, firm fixed-price delivery order was executed on October 23, 2025, with an ultimate completion date of October 24, 2025. The contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. This delivery order is...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCT1SDelivery Order
The Defense Logistics Agency awarded a $11,136.57 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Biktarvy 50-200-25 mg tablets (30-count units). The contract, which is a non-set-aside award issued through competitive procurement, requires completion by December 8, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger indefinite delivery vehicle and reflects the company's ongoing role as a critical pharmaceutical supplier to federal military and healthcare systems. This award falls under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. That prime vendor contract serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply medications, vaccines, and medical supplies across multiple therapeutic domains to military healthcare programs worldwide. AmerisourceBergen's consistent receipt of non-set-aside, competitively awarded delivery orders demonstrates its capability to meet federal procurement requirements and its significant position within the Defense Health Agency's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 12/4/25 |